Efficacy and safety of hyperbaric oxygen therapy for acute central retinal artery occlusion in Hong Kong: results of the first 3 years


  • Sunny, Chi Lik Au Tung Wah Eastern Hospital
  • Steffi, Shing Yee Chong
  • Po Lin Leow
  • Callie, Ka Li Ko


COVID-19, Hyperbaric Oxygenation, Retinal arterial microaneurysm, Retinal artery occlusion


Purpose: To review the efficacy and safety of hyperbaric oxygen therapy (HBOT) for central retinal artery occlusion (CRAO) in Hong Kong patients.
Methods: Patients diagnosed with CRAO with symptom onset ≤6 hours who failed emergency bedside ocular treatment were referred to a course of HBOT. Changes in best corrected visual acuity (VA) after HBOT and adverse effects and complications of HBOT were recorded. Changes in best corrected VA between the pre-COVID-19 group and the COVID-19-pandemic group were compared.
Results: 34 men and 26 women with CRAO aged 27 to 89 years were included for analysis. The mean follow-up period was 169±226 days. The mean number of HBOT sessions received was 8.6±3.2. The mean best corrected VA improved from 2.02±0.36 to 1.53±0.61 logMAR after HBOT (p<0.00001). 65% of patients had improvement and 33.3% had no improvement. VA changes between the pre-COVID-19 group (n=22) and COVID-19-pandemic group (n=38) were comparable (-0.53±0.58 vs -0.46±0.57 logMAR, p=0.59), despite a delay in hospital attendance. 41.7% of patients failed to equalize the pressure during treatment requiring myringotomy or even grommet insertion. 20% of patients had barotrauma. Other adverse events included convulsion, confusion, sinus pain, and hypoglycemia.
Conclusion: In patients with CRAO, HBOT is effective in improving best corrected VA, even during the COVID-19 pandemic.


Flaxel CJ, Adelman RA, Bailey ST, et al. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®. Ophthalmology 2020;127:P259-P287.

Au SCL, Ko CKL. Ocular stroke and COVID-19. Hong Kong Med J 2021;27:231.

Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond) 2013;27:688-97.

Cugati S, Varma DD, Chen CS, Lee AW. Treatment options for central retinal artery occlusion. Curr Treat Options Neurol 2013;15:63-77.

Dumitrascu OM, Newman NJ, Biousse V. Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuroophthalmol 2020;40:333-45.

Kim YS, Nam MS, Park EJ, et al. The effect of adjunctive hyperbaric oxygen therapy in patients with central retinal artery occlusion. Undersea Hyperb Med 2020;47:57-64.

Wu X, Chen S, Li S, et al. Oxygen therapy in patients with retinal artery occlusion: a meta-analysis. PLoS One 2018;13:e0202154.

Yip LT, Au SCL, Ko CKL. Hyperbaric oxygen therapy for central retinal artery occlusion: experience in Hong Kong. Hong Kong J Ophthalmol 2020;24:44-50.

Au SCL, Ko CKL. Impact of COVID-19 on acute central retinal artery occlusion patient attendance in Hong Kong: the HORA study brief report number 2. Acta Sci Clin Case Rep 2021;2:1-2.

Au SCL. Central retinal artery occlusion in COVID-19. Indian J Ophthalmol 2021;69:2905-6.

Au SCL, Ko CKL. Comments on coronavirus positive patients presenting with stroke-like symptoms. J Stroke Cerebrovasc Dis 2021;30:105741.

Au SCL, Ko CKL. Prevalence of SARS-CoV-2 among central retinal artery occlusion patients: a case series-HORA study report No. 3. J Acute Dis 2021;10:147-9.

Au SCL, Ko CKL. Delayed hospital presentation of acute central retinal artery occlusion during the COVID-19 crisis: the HORA study brief report No. 4. Indian J Ophthalmol 2021;69:2904-5.

Schmidt I, Walter P, Siekmann U, et al. Development of visual acuity under hyperbaric oxygen treatment (HBO) in non arteritic retinal branch artery occlusion. Graefes Arch Clin Exp Ophthalmol 2020;258:303-10.

Wang J, Huang J, Cheung CSK, Wong WN, Cheung NT, Wong MC. Adoption of an electronic patient record sharing pilot project: cross-sectional survey. J Med Internet Res 2020;22:e13761.

Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories ‘hand motion’ and ‘counting fingers’ using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol 2009;247:137-42.

Ledolter J, Gramlich OW, Kardon RH. Display of data. Invest Ophthalmol Vis Sci 2020;61:25.

O’Neill OJ, Weitzner ED. The O’Neill grading system for evaluation of the tympanic membrane: a practical approach for clinical hyperbaric patients. Undersea Hyperb Med 2015;42:265-71.

Hadanny A, Maliar A, Fishlev G, et al. Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen. Clin Ophthalmol 2016;11:115-25.

Mir TA, Arham AZ, Fang W, et al. Acute vascular ischemic events in patients with central retinal artery occlusion in the United States: a nationwide study 2003-2014. Am J Ophthalmol 2019;200:179-86.

Chodnicki KD, Tanke LB, Pulido JS, et al. Stroke risk before and after central retinal artery occlusion: a population-based analysis. Ophthalmology 2022;129:203-8.

Chodnicki KD, Pulido JS, Hodge DO, Klaas JP, Chen JJ. Stroke risk before and after central retinal artery occlusion in a US cohort. Mayo Clin Proc 2019;94:236-41.

Chang YS, Jan RL, Weng SF, et al. Retinal artery occlusion and the 3-year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol 2012;154:645-52.e1.

Nasole E, Zanon V, Marcolin P, Bosco G. Middle ear barotrauma during hyperbaric oxygen therapy; a review of occurrences in 5,962 patients. Undersea Hyperb Med 2019;46:101-6.

Karahatay S, Yilmaz YF, Birkent H, Ay H, Satar B. Middle ear barotrauma with hyperbaric oxygen therapy: incidence and the predictive value of the nine-step inflation/deflation test and otoscopy. Ear Nose Throat J 2008;87:684-8.

Edinguele WFOP, Barberon B, Poussard J, Thomas E, Reynier JC, Coulange M. Middle-ear barotrauma after hyperbaric oxygen therapy: a five-year retrospective analysis on 2,610 patients. Undersea Hyperb Med 2020;47:217-28.

Peleg RK, Fishlev G, Bechor Y, et al. Effects of hyperbaric oxygen on blood glucose levels in patients with diabetes mellitus, stroke or traumatic brain injury and healthy volunteers: a prospective, crossover, controlled trial. Diving Hyperb Med 2013;43:218-21.

Stevens SL, Narr AJ, Claus PL, et al. The incidence of hypoglycemia during HBO2 therapy: a retrospective review. Undersea Hyperb Med 2015;42:191-6.

Baitule S, Patel AH, Murthy N, et al. A systematic review to assess the impact of hyperbaric oxygen therapy on glycaemia in people with diabetes mellitus. Medicina (Kaunas) 2021;57:1134.

Murphy-Lavoie H, Butler F, Hagan C. Arterial inefficiencies: central renal artery occlusion. In: Lindell KW, editor. Hyperbaric Oxygen Therapy Indication, 13th ed. Durham, NC: Best Publishing Company; 2014: 11-24.

Pereira LS, Yoon MK, Hwang TN, et al. Giant cell arteritis in Asians: a comparative study. Br J Ophthalmol 2011;95:214-6.

Au SCL. A surge in eye clinic nonattendance under 2019 novel coronavirus outbreak. Indian J Ophthalmol 2020;68:948.




How to Cite

Au SCL, Chong SSY, Leow PL, Ko CKL. Efficacy and safety of hyperbaric oxygen therapy for acute central retinal artery occlusion in Hong Kong: results of the first 3 years. Hong Kong J Ophthalmol [Internet]. 2022Jun.29 [cited 2024Jun.15];26(1). Available from: https://hkjo.hk/index.php/hkjo/article/view/323



Original Articles